LeadingAge New York Adviser Fall 2015 Vol. 1 - Page 16

Feature Therapy’s Role in Dementia Management Success: We build on it . T he Centers for Medicare and Medicaid Services (CMS) announced in March 2012 the Partnership to Improve Dementia Care, an initiative aimed at reducing use of antipsychotic drugs in nursing home residents by 15 percent. Central to this initiative was enhanced training for providers regarding high quality person-centered care, publicly-reported data and emphasis on nonpharmacological interventions for common dementia-related behaviors including consistent staff assignments and pain management strategies. According to data from the Certification and Survey Provider Enhanced Reporting (CASPER) data network from CMS, over 25 percent of residents in nursing facilities in the United States receive antipsychotic medications. While these drugs have legitimate uses including treatment for psychotic disorders such as schizophrenia, delusions and hallucinations, they are often used inappropriately in nursing facilities to treat behavioral symptoms related to dementia. Patrick Conway, M.D., CMS chief medical officer and director of clinical standards and quality stated, “a CMS nursing home resident report found that … patients with signs of dementia were receiving antipsychotic drugs, even though there was no diagnosis of psychosis. Managing dementia without relying on medication can